VP
Valeo Pharma Inc.
VPHIF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $14.0K
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
EV/FFO N/A
P/E N/A
Growth
100 /100
Growing Rev. growth 93.25%
Book val. growth N/A
EPS growth N/A
Profitability
8 /100
Weak Op. margin 31.96%
Gross margin 24.26%
FCF margin 39.41%
Quality
21 /100
Poor Asset turnover 1.31x
ROIC 67.29%
ROA 67.48%
Debt
23 /100
High Int. coverage -1.02x
Current ratio 1.25x
Debt/Assets N/A
Stability
54 /100
Moderate EPS volatility 71.97%
Beta 0.81x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VPHIF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kyle Steiger
Employees
70
Headquarters
Kirkland
Upcoming events
30 DEC
Earnings
Upcoming earnings report